Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2006 2
2008 2
2009 4
2010 3
2011 2
2012 2
2017 1
2020 2
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis.
Loureiro D, Tout I, Narguet S, Bed CM, Roinard M, Sleiman A, Boyer N, Pons-Kerjean N, Castelnau C, Giuly N, Tonui D, Soumelis V, El Benna J, Soussan P, Moreau R, Paradis V, Mansouri A, Asselah T. Loureiro D, et al. Among authors: castelnau c. Hepatology. 2023 Apr 1;77(4):1348-1365. doi: 10.1002/hep.32731. Epub 2022 Sep 16. Hepatology. 2023. PMID: 35971873 Free PMC article.
New therapies for hepatitis delta virus infection.
Loureiro D, Castelnau C, Tout I, Boyer N, Narguet S, Menasria Benazzouz S, Louis Z, Pons-Kerjean N, Giuly N, Marcellin P, Mansouri A, Asselah T. Loureiro D, et al. Among authors: castelnau c. Liver Int. 2021 Jun;41 Suppl 1:30-37. doi: 10.1111/liv.14838. Liver Int. 2021. PMID: 34155804 Review.
Future treatments for hepatitis delta virus infection.
Asselah T, Loureiro D, Tout I, Castelnau C, Boyer N, Marcellin P, Mansouri A. Asselah T, et al. Among authors: castelnau c. Liver Int. 2020 Feb;40 Suppl 1:54-60. doi: 10.1111/liv.14356. Liver Int. 2020. PMID: 32077603 Review.
[Treatment of chronic hepatitis B].
Asselah T, Castelnau C, Boyer N, Ripault MP, Marcellin P. Asselah T, et al. Among authors: castelnau c. Gastroenterol Clin Biol. 2004 Dec;28(12):1215-27. doi: 10.1016/s0399-8320(04)95213-x. Gastroenterol Clin Biol. 2004. PMID: 15671931 Free article. Review. French. No abstract available.
[Treatment of chronic hepatitis B].
Asselah T, Castelnau C, Marcellin P. Asselah T, et al. Among authors: castelnau c. Presse Med. 2006 Feb;35(2 Pt 2):327-34. doi: 10.1016/s0755-4982(06)74578-x. Presse Med. 2006. PMID: 16493337 Review. French.
The current status of antiviral therapy of chronic hepatitis B.
Asselah T, Ripault MP, Castelnau C, Giuily N, Boyer N, Marcellin P. Asselah T, et al. Among authors: castelnau c. J Clin Virol. 2005 Dec;34 Suppl 1:S115-24. doi: 10.1016/s1386-6532(05)80020-4. J Clin Virol. 2005. PMID: 16461210 Review.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
Roulot D, Brichler S, Layese R, BenAbdesselam Z, Zoulim F, Thibault V, Scholtes C, Roche B, Castelnau C, Poynard T, Chazouillères O, Ganne N, Fontaine H, Gournay J, Guyader D, Le Gal F, Nahon P, Roudot-Thoraval F, Gordien E; Deltavir study group. Roulot D, et al. Among authors: castelnau c. J Hepatol. 2020 Nov;73(5):1046-1062. doi: 10.1016/j.jhep.2020.06.038. Epub 2020 Jul 4. J Hepatol. 2020. PMID: 32634548 Free article.
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-life.
Asselah T, Loureiro D, Le Gal F, Narguet S, Brichler S, Bouton V, Abazid M, Boyer N, Giuly N, Gerber A, Tout I, Maylin S, Bed CM, Marcellin P, Castelnau C, Gordien E, Mansouri A. Asselah T, et al. Among authors: castelnau c. Liver Int. 2021 Jul;41(7):1509-1517. doi: 10.1111/liv.14950. Epub 2021 Jun 8. Liver Int. 2021. PMID: 33999515
22 results